Works matching IS 1021335X AND DT 2022 AND VI 47 AND IP 2


Results: 21
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.

    Published in:
    Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
    By:
    • Tanaka, Ken;
    • Kandori, Shuya;
    • Sakka, Shotaro;
    • Nitta, Satoshi;
    • Tanuma, Kozaburo;
    • Shiga, Masanobu;
    • Nagumo, Yoshiyuki;
    • Negoro, Hiromitsu;
    • Kojima, Takahiro;
    • Mathis, Bryan J.;
    • Shimazui, Toru;
    • Watanabe, Makoto;
    • Sato, Taka-Aki;
    • Miyamoto, Takafumi;
    • Matsuzaka, Takashi;
    • Shimano, Hitoshi;
    • Nishiyama, Hiroyuki
    Publication type:
    Article
    21